CSL Limited
CSL
Rank in Stocks
#362
CSL Limited operates as a global biopharmaceutical company, engaged in the... CSL Limited operates as a global biopharmaceutical company, engaged in the research, development, manufacturing, marketing, and distribution of diverse pharmaceutical and allied products. Its extensive international footprint includes key markets such as Australia, the United States, Germany, the United Kingdom, Switzerland, and China. The company is structured into two principal operating segments: CSL Behring and CSL Seqirus. CSL Behring focuses on plasma-derived therapies, encompassing both plasma products and recombinant treatments. This segment also conducts significant research into both plasma and non-plasma therapeutics and derives revenue from intellectual property licensing and royalties. In contrast, CSL Seqirus is dedicated to the manufacturing and worldwide distribution of non-plasma biotherapeutic products, alongside developing a range of influenza-related solutions. Founded in 1916, CSL Limited maintains its corporate headquarters in Parkville, Australia.
Share Price
$138.58
Market Cap
$66.50B
Change (1 day)
0.72%
Change (1 year)
-2.29%
Country
AU
Trade CSL Limited (CSL)
Category
Healthcare
Stock split history for CSL Limited (CSL)
CSL Limited stock (symbol: CSL) underwent a total of 1 stock splits.
The most recent stock split occurred on Oct 18, 2007.
One CSL share bought prior to Oct 18, 2007 would equal to 3 CSL shares today.
The most recent stock split occurred on Oct 18, 2007.
One CSL share bought prior to Oct 18, 2007 would equal to 3 CSL shares today.
Stock split list
| Year | Split | Multiple | Cumulative Multiple |
|---|---|---|---|
| 2007-10-18 | 3:1 | x3 | x3 |
Stock splits for similar companies or competitors
| Company | Number of stock splits | Cumulative Multiple | Country |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
|
| 1 | x100 |
BE
|
